Current Status of Pharmaceutical and Genetic Therapeutic Approaches to Treat DMD
Molecular Therapy2011Vol. 19(5), pp. 830–840
Citations Over TimeTop 1% of 2011 papers
Christophe Pichavant, Annemieke Aartsma‐Rus, Paula R. Clemens, Kay E. Davies, George Dickson, Shin’ichi Takeda, Steve D. Wilton, Jon A. Wolff, Christine I. Wooddell, Xiao Xiao, Jacques P. Tremblay
Related Papers
- → Efficacy of systemic morpholino exon‐skipping in duchenne dystrophy dogs(2009)392 cited
- → Current Translational Research and Murine Models For Duchenne Muscular Dystrophy(2016)62 cited
- → Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-deficient mdx Mice(2015)29 cited
- → A Dystrophin Exon-52 Deleted Miniature Pig Model of Duchenne Muscular Dystrophy and Evaluation of Exon Skipping(2021)14 cited
- → Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy(2014)6 cited